Current Views on the Pathophysiology of GB Virus C Coinfection with HIV-1 Infection
- 16 October 2010
- journal article
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 13 (1) , 47-52
Abstract
GB virus C (GBV-C), a member of the Flaviviridae family of viruses, recently received considerable attention largely owing to its potential role in decelerating HIV-1 disease progression by interfering with HIV replication. With similar transmission features, GBV-C is parenterally transmitted, similar to the serum hepatitis viruses and HIV-1, and replicates in hemopoietic cells and T lymphocytes in particular, with no observable disease pathology. Progressive T-cell depletion and subsequent immune abrogation being the cardinal features of HIV-1 infection, accumulating evidence indicates that GBV-C effectively overturns HIV’s chances of exploiting the T-cell machinery and leads to enhanced survival rates of HIV-infected subjects. Much effort has been devoted to understanding the beneficial role of GBV-C in HIV disease. This review discusses recently proposed mechanisms underlying the pathophysiology of GBV-C coinfection in HIV disease.Keywords
This publication has 53 references indexed in Scilit:
- GB Virus Type C Envelope Protein E2 Elicits Antibodies That React with a Cellular Antigen on HIV-1 Particles and Neutralize Diverse HIV-1 IsolatesThe Journal of Immunology, 2010
- GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4 + T-cellsAntiviral Therapy, 2010
- Viruses within the Flaviviridae Decrease CD4 Expression and Inhibit HIV Replication in Human CD4+ CellsThe Journal of Immunology, 2009
- GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapyAIDS, 2009
- Impact of HIV on Cell Survival and Antiviral Activity of Plasmacytoid Dendritic CellsPLOS ONE, 2007
- An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4 + Jurkat T cellsProceedings of the National Academy of Sciences, 2006
- An Immune Basis for Malaria Protection by the Sickle Cell TraitPLOS Medicine, 2005
- Hepatitis C virus NS5A: tales of a promiscuous proteinJournal of General Virology, 2004
- Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32Journal of Biological Chemistry, 1997
- Acute Non-A–E Hepatitis in the United States and the Role of Hepatitis G Virus InfectionNew England Journal of Medicine, 1997